CASP3 and systemic inflammatory response syndrome: A study found that apoptotic adipose-derived mesenchymal stem cell therapy reduced inflammatory, oxidative, and apoptotic (Bax, caspase-3) biomarkers, increased antiapoptotic (Bcl-2) and antioxidant biomarkers, and protected against lung and kidney injury in the sepsis syndrome caused by CLP in rats [39].